share_log

Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston

SEC ·  Aug 30, 2024 04:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more